$SYRA

Syra Health Corp

CIK:0001922335|SEC Filings

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
Statements of Operations (Unaudited) - USD ($)	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net revenues	$ 2,394,423	$ 1,946,199	$ 4,667,943	$ 3,803,973
Cost of services	1,328,120	1,193,304	2,630,385	2,461,922
Gross profit	1,066,303	752,895	2,037,558	1,342,051
Operating expenses:
Salaries and benefits	392,136	326,354	764,245	833,561
Professional services	138,019	164,939	325,160	388,965
Research and development expenses	47,351	29,712	54,272	66,885
Selling, general and administrative expenses	236,485	289,070	449,532	576,357
Depreciation	741	5,978	1,795	12,775
Total operating expenses	814,732	816,053	1,595,004	1,878,543
Operating income (loss)	251,571	(63,158)	442,554	(536,492)
Other income (expense):
Interest income	888	3,420	53,346	7,718
Interest expense	(2,217)	(3,858)	(4,679)	(7,087)
Total other income (expense)	(1,329)	(438)	48,667	631
Net income (loss)	$ 250,242	$ (63,596)	$ 491,221	$ (535,861)
Weighted average common shares outstanding - basic	13,175,433	11,939,169	12,560,716	11,764,086
Weighted average common shares outstanding - diluted	13,551,931	11,939,169	12,937,216	11,764,086
Net income (loss) per common share - basic	$ 0.02	$ (0.01)	$ 0.04	$ (0.05)
Net income (loss) per common share - diluted	$ 0.02	$ (0.01)	$ 0.04	$ (0.05)

Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Jun. 30, 2026	Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 491,221	$ (535,861)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	1,795	12,775
Common stock issued for services		2,586
Stock-based compensation	44,439	54,067
Changes in operating assets and liabilities:
Accounts receivable	(551,649)	(205,534)
Other current assets	141,516	157,985
Right-of-use asset	29,877	277,029
Accounts payable	(51,926)	455,366
Accounts payable, related party	53,000
Deferred revenue	489,275	250,000
Accrued expenses	25,512	(105,630)
Operating lease liability	(29,877)	(277,029)
Net cash provided by operating activities	643,183	85,754
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from sale of common stock and exercise of warrants		14,800
Repayments on notes payable	(134,169)	(190,035)
Net cash used in financing activities	(134,169)	(175,235)
NET CHANGE IN CASH AND CASH EQUIVALENTS	509,014	(89,481)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	1,614,733	2,395,405
CASH AND CASH EQUIVALENTS AT END OF PERIOD	2,123,747	2,305,924
SUPPLEMENTAL INFORMATION:
Interest paid	4,679	7,087
Income taxes paid
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of Class B common stock to Class A common stock	2,500	2,333
Recognition of right-of-use asset and lease liability	80,120
Prepaid asset financed with note payable	$ 89,477	$ 123,866

Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 2,123,747	$ 1,614,733
Accounts receivable, net	1,470,023	918,374
Other current assets	153,384	205,423
Total current assets	3,747,154	2,738,530
Property and equipment, net	5,192	6,986
Right-of-use asset	77,644	27,401
Total assets	3,829,990	2,772,917
Current liabilities:
Accrued expenses	220,333	194,821
Deferred revenue	505,886	16,611
Current portion of operating lease liability, related party	77,644	27,401
Notes payable	71,694	116,386
Total current liabilities	1,196,152	674,739
Non-current portion of operating lease liability, related party
Total liabilities	1,196,152	674,739
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares designated, issued and outstanding
Additional paid-in capital	11,848,954	11,806,765
Accumulated deficit	(9,229,305)	(9,720,526)
Total stockholders’ equity	2,633,838	2,098,178
Total liabilities and stockholders’ equity	3,829,990	2,772,917
Common Class A [Member]
Stockholders’ equity:
Common stock, value	13,839	11,339
Convertible Class B Common Stock [Member]
Stockholders’ equity:
Common stock, value	350	600
Nonrelated Party [Member]
Current liabilities:
Accounts payable, related party	195,595	247,520
Related Party [Member]
Current liabilities:
Accounts payable, related party	$ 125,000	$ 72,000